Although conditioned inhibition of fear (or learned safety) is a learning process critical for preventing chronic stress, a predisposing factor for depression and other psychopathologies, little is known about its functional purposes or molecular mechanisms. To obtain better insight into learned safety, we investigated its behavioral and molecular characteristics and found that it acts as a behavioral antidepressant in two animal models. Learned safety promotes the survival of newborn cells in the dentate gyrus of the hippocampus, while its antidepressant effect is abolished in mice with ablated hippocampal neurogenesis. Learned safety also increases the expression of BDNF in the hippocampus and leads to downregulation of genes involved in the dopaminergic and neuropeptidergic but not the serotonergic system in the basolateral amygdala. These data suggest that learned safety is an animal model of a behavioral antidepressant that shares some neuronal hallmarks of pharmacological antidepressants but is mediated by different molecular pathways.
INTRODUCTION
Instinctive and learned fear are essential for survival and are evolutionarily conserved in organisms ranging from simple invertebrates to mammals. In humans, pathological forms of learned fear are hallmarks of severe psychopathologies such as anxiety disorders, posttraumatic stress disorders, and depression. The fact that fear can be enhanced through learning and can become a symptom of psychopathology in humans suggests that this form of learning may not always be appropriate and might, in certain situations, lead to unfavorable consequences. Therefore, it seems likely that effective inhibitory constraints exist that prevent the inappropriate expression of learned fear.
In search for such a mechanism, Robert Rescorla extended the early work of Ivan Pavlov and delineated ''conditioned inhibition'' as a learning paradigm whereby a neutral CS develops the ability to inhibit responses to learned predictors of aversive or rewarding stimuli (Pavlov, 1927; Rescorla, 1969) . Fear conditioning results from a positive correlation (pairing) of a previously neutral CS and an aversive US. During conditioned inhibition, by contrast, a CS that is negatively correlated (explicitly unpaired) with an aversive US becomes a positive signal (predictor) for safety and reduces the expression of conditioned fear. Since the animal associates the target signal with protection from an impending aversive event, conditioned inhibition has been thought to represent a form of learned safety, a process by which the animal learns to take advantage of sources of safety and security in the environment (Candido et al., 2004; Dinsmoor, 2001; Wiertelak et al., 1992) . The term ''safety signal'' generally refers to a stimulus that is inversely or negatively correlated to an aversive event (Candido et al., 2004) . In our previous study, we referred to learned safety as the learning and memory resulting from a conditioned inhibition training procedure (Rogan et al., 2005) . We here attempt to first characterize some of the behavioral consequences of learned safety and then to go on to explore it at the molecular level.
The ability to identify events that afford relief from ongoing strain is thought to be crucial for the prevention of chronic stress, a precipitating factor for the development of anxiety disorders and depression (Chan et al., 2001; Davis and Shi, 1999; LeDoux, 1993; Rogan et al., 2001 ). This led us to investigate whether learned safety, as a predictor of a break from continuously imminent, stress-producing danger, may have antidepressant effects. We tested this idea in mice using the forced-swim test and the unpredictable chronic mild stress (UCMS) paradigm. We then assessed whether learned safety could also share some major neuronal characteristics of pharmacological antidepressant treatments, specifically modulation of neurogenesis and the expression of BDNF in the dentate gyrus of the hippocampus (Warner-Schmidt and Duman, 2006; Dranovsky and Hen, 2006; Malberg and Duman, 2003) .
The amygdala is a key structure for the pathogenesis of the dominant emotional symptoms in major depression. To examine the molecular mechanisms contributing to learned safety using Affymetrix high-density oligonucleotide arrays, we focused on the basolateral nucleus, the subregion of the amygdala where we have previously described distinct electrophysiological features of learned safety (Rogan et al., 2005) .
RESULTS

The Safety Signal Is a Conditioned Inhibitor that Leads to Reduction of Conditioned Contextual Fear and Retards Subsequent Fear Conditioning
Safety conditioning is carried out over 3 days, one session per day, and comprises a simple conditioned inhibition of fear paradigm consisting of several explicitly unpaired presentations of the aversive US and the tone CS (see Figure 1A) . After safety training, freezing (the endogenous defense response of rodents) to the experimental context in the presence of the CS is significantly reduced in safety-trained mice and significantly increased in fear-conditioned mice, while remaining unchanged in tone controls ( Figure 1B ). This observation provides evidence for summation, one of the two defining criteria of a conditioned inhibitor (Rescorla, 1971) . The second test that a true conditioned inhibitor needs to pass is retardation. Indeed, we found that, when mice were fear conditioned to the same CS used beforehand in safety training, they do not show freezing to the tone after 1 day of fear training ( Figure 1C ). However, with an additional day of fear training, previously safety-conditioned animals also learn to freeze to the CS ( Figure 1D ).
To further rule out nonspecific excitatory effects of the safety signal, we tested whether a different tone (CS*) that has not A) Safety conditioning consists of a simple conditioned inhibition of learned fear paradigm in which the delivery of four shock US is followed by the presentation of four tone CS. In the fear conditioning protocol, the number of CS and US presentations is matched to the safety conditioning paradigm (four paired CS-US). Training is conducted over a period of 3 days, one session per day. A memory recall test, consisting of a single CS presentation, is carried out 24 hr after the last training day. (B) Contextual freezing in the presence of the CS (n = 10-14 per group) (main effect of type of training [i.e., learned safety, learned fear, or tone-alone control]: F (2,31) = 34.813, p < 0.001; effect of interaction between type of training and phase of testing [i.e., pre-CS or CS]: F (2,31) = 24.715, p < 0.001; Tukey-Kramer post hoc test for type of training [CS phase]: safety versus fear and safety versus tone p < 0.001; fear versus tone p < 0.001). Separate paired Student's t tests (pre-CS versus CS) within each group reveal the ''CS effect'' (learned safety, p < 0.001; learned fear, p < 0.01; tone alone, p > 0.05). (C) CS response after 1 day of fear conditioning in previously naive control and previously safety conditioned mice (n = 7 per group) (effect of interaction between phase of testing and type of training: F (1,14) = 255.462, p < 0.001). ''CS effect'' (learned safety, p < 0.001; naive control, p < 0.001). Student's t test between CS phases (p < 0.001). (D) CS response after 2 days of fear conditioning in previously naive control and previously safety conditioned mice (n = 7 per group) (main effect of phase of testing F (1,14) = 47.245: p < 0.001). ''CS effect'' (learned safety, p < 0.01; naive control, p < 0.001). (E) Contextual freezing in response to the conditioned CS and an unconditioned tone CS* (n = 7 per group) (main effect of phase of testing F (1,14) = 14.763: p < 0.01; main effect of type of CS F (1,14) = 6.995: p < 0.05; effect of interaction F (1,14) = 21.086: p < 0.001). ''CS effect'' (CS, p < 0.001; CS*, p > 0.05). Student's t test between CS phases (p < 0.001). All data are depicted as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.0001, n.s. (not significant) p > 0.05. been explicitly unpaired with the US would reduce freezing to the context in the memory recall test. We found that the CS, but not the CS*, reduced contextual freezing in safety-trained mice ( Figure 1E ).
Learned Safety Reduces Innate Fear in the Elevated Plus Maze
Using a within-subject control design, we tested whether the presence of the conditioned stimulus would act to modulate behavioral measures associated with reduced anxiety in the elevated plus maze. We found significantly increased numbers of open arm entries in safety-conditioned mice in the presence of the CS (Figure 2A ). Closed arm entries were significantly decreased in safety-conditioned mice and increased in fearconditioned mice during delivery of the CS ( Figure 2B ). Moreover, safety-conditioned mice spent significantly more time in the open arms in the CS than in the no-CS period, whereas the opposite effect was observed in fear-conditioned mice ( Figure 2C ).
Learned Safety Can Serve as a Behavioral Antidepressant
Delivery of the Safety Signal Reduces Immobility in the Forced-Swim Test Immobility in the forced-swim test, interpreted as a form of behavioral despair, was significantly reduced in safety-conditioned mice in the presence of the safety signal ( Figure 3A) . We then evaluated, in safety-trained mice, the effect of fluoxetine on immobility in the forced-swim test, in order to validate the antidepressant activity of the safety signal with respect to a widely used pharmacological antidepressant. Vehicle-and fluoxetinetreated mice were either exposed to the safety signal during the forced-swim test (CS groups) or served as control (no-CS groups). We found that the percentage of time spent immobile in the vehicle-treated CS group and the fluoxetine-treated no-CS group was not different, suggesting that the reduction in immobility induced by the safety signal is comparable to the effect seen with the antidepressant fluoxetine. Immobility was even further decreased in the presence of the safety signal in fluoxetine-treated safety-trained mice ( Figure 3B ).
Learned Safety Reduces Anhedonia Brought on by Unpredictable Chronic Mild Stress
We found that a 4 week exposure to unpredictable chronic mild stress induced a significantly increased response for learned safety in the memory recall test ( Figure 3C ). The depressive state induced by UCMS is associated with anhedonic behavior that can be assessed in the sucrose preference test. As expected, all mice showed abolished sucrose preference following UCMS treatment. In UCMS-treated safety-trained mice, sucrose preference was restored to levels of unstressed controls when assessed in the presence of the safety signal. The safety signal had no effect on sucrose preference in tone-alone controls ( Figure 3D ).
Safety Learning Promotes the Survival of Newborn Cells in the Hippocampal Dentate Gyrus
To determine whether safety learning has an effect on adultgenerated hippocampal neurons, we examined the number and the fate of newborn cells using labeling with the thymidine analog bromodeoxyuridine (BrdU). We employed two paradigms: the ''survival paradigm'' and the ''proliferation paradigm'' ( Figure 4A ) (Gould et al., 1999; Malberg et al., 2000) . We found that learned safety significantly enhanced the number of newborn cells surviving 2 weeks after BrdU administration ( Figures  4B-4E) . Results from the proliferation paradigm indicate that learned safety did not affect the rate of neurogenesis.
Ablation of Hippocampal Neurogenesis Retards Safety Learning
We used x-irradiation of the dentate gyrus to ablate hippocampal neurogenesis in mice and verified the absence of newly generated cells by doublecortin immunohistochemistry (a marker for neurons younger than 1 month of age) 6 weeks later (Figure S1 available online). We then tested the effect of ablated hippocampal neurogenesis on learned safety and found that x-irradiated mice showed no evidence of safety learning after 1 day of training, in contrast to sham-irradiated control mice ( Figure 5A ). However, after an additional 2 days of training, both x-irradiated and sham mice displayed significant reduction of contextual freezing when exposed to the safety signal ( Figure 5B ). In contrast to learned safety, fear conditioning was not affected by ablation of hippocampal neurogenesis on either day.
Ablation of Neurogenesis Inhibits the Antidepressant Action of Learned Safety
When evaluating the potential of learned safety to reduce depression-like behaviors, we found that safety trained x-irradiated mice did not show reduced immobility in the presence of the safety signal, which was observed in the controls ( Figure 5C ). Moreover, UCMS-induced enhancement of the safety response was absent ( Figure 5D ), and the ability of learned safety to rescue the UCMS-induced reduction of sucrose preference was abolished in x-irradiated safety-trained mice ( Figure 5E ). 
Safety Learning Increases Expression of BDNF in the Dentate Gyrus of the Hippocampus
BDNF is known to be induced by antidepressant treatment in the hippocampus, particularly in the dentate gyrus (Nibuya et al., 1995; Russo-Neustadt et al., 2004) , and could be responsible for the increase in and survival of hippocampal neurons following antidepressant drug treatment (Duman, 2004a (Duman, , 2004b . This led us to analyze the expression of BDNF in the dentate gyrus in mice following safety and fear training together with tone-alone controls. Using immunohistochemical analysis, we found increased BDNF expression in safety-conditioned mice, whereas the expression of BDNF in fear-conditioned mice was reduced as compared to tone-alone controls ( Figure 6 ).
Genes Differentially Expressed in the Basolateral
Amygdala of Safety-Conditioned and Fear-Conditioned Mice To characterize the molecular mechanisms involved in safety learning, we searched for genes whose mRNAs were differentially regulated in safety-and fear-conditioned mice in the basolateral nucleus of the amygdala. We isolated the basolateral nucleus of the amygdala using laser-capture microdissection (LCM), which permits for rigorously controlled and precise isolation of the target nucleus without contamination from surrounding areas ( Figure 7A ). Using a combination of hypothesis-free and hypothesis-driven approaches, we examined all significant changes (80 specific probe sets) ( Figure 7B and Table S1 ) but thereafter also focused on certain candidate genes that have been implicated in the literature to be involved in stress, anxiety, and depression (Table S2) .
We found differential regulation of four genes (dopamine D2 receptor, substance P, prodynorphin, and preproenkephalin 1) that have been highly implicated in the response to endogenous and exogenous stressors and depression (McLaughlin et al., 2003; Sinchak et al., 2000) . To independently verify the observed changes and to relate them to benchmark values, we carried out RT-PCR analyses for two of these genes-dopamine D2 receptor (D2R) and substance P (SP)-those on which we focused more in subsequent experiments. In addition, RNA isolated from LCM samples of handled-only mice as naive baseline controls was included ( Figures 7C and 7D ).
Blocking D2 Receptors Facilitates the Memories for Learned Safety
To evaluate the importance of the gene expression findings in vivo, we examined the effects of blockade of D2R on the memory for learned safety. We found that the treatment with the D2R antagonist sulpiride before the memory recall test led to a significant enhancement of the safety response ( Figure 8A ). When sulpiride was administered before the training sessions and mice were tested drug free, no effect in either safety-or fear-trained mice was observed ( Figure S2A ). Application of the D2R agonist quinprinole before the memory recall test ( Figure 8B ) but not before the training sessions ( Figure S2B ) abolished the safety response in the memory recall test. Quinprinole treatment did not affect learned fear under either condition.
A significant interaction between CS delivery and drug administration was revealed when we trained mice drug free in the learned safety paradigm and administered sulpiride before the forced-swim test. This result suggests that dopaminergic transmission is an important, although not the exclusive, mediator of learned safety ( Figure 8C ).
Blocking NK-1 Receptors Facilitates the Acquisition of Learned Safety
To determine the importance of Substance P in vivo, we first tested the effect of blockade of the preferred receptor for Substance P, the NK-1 receptor, using L-703,606. We found that the response to the safety CS was not different in L-703,606-treated and vehicle-treated mice in both safety-and fearconditioned mice when mice were trained drug free and NK-1 receptors were blocked only during the memory recall test (Figure S2C) . However, when we trained mice under the influence of L-703,606 and then tested them drug free, we observed a significantly enhanced safety response in L-703,606-treated mice whereas the response to the CS was not altered in fear-conditioned mice. NK-1 inhibition during training did not affect the CS response in the memory recall test ( Figure 8D ). Application of the NK-1 agonist ([Sar9, Met(O2)11]-Substance P) before the memory recall test did not affect learned safety ( Figure S2D ). However, when we exposed the animals to the NK-1 agonist before each training session, we observed a reduced safety response during the memory recall test ( Figure 8E ). The learned fear response was not affected by drug treatment under either condition. (Bowen et al., 1989; Drevets et al., 1999) and in the response to antidepressants (Li et al., 1998; Singh and Lucki, 1993) . However, blockade of 5-HT 1A receptors affected learned safety neither in the acquisition nor in the memory recall phase (Figures 8F and 8G ).
DISCUSSION
We find that learned safety reduces depression-like behavior in mice. Consistent with its behavioral antidepressant effects, learned safety enhances the survival of newborn cells and leads to increased expression of BDNF in the hippocampal dentate gyrus. In the amygdala, learned safety strongly modulates the expression of key components of the dopaminergic and neuropeptidergic system while having no effect on elements of the serotonergic transmission. Learned safety thus exerts its antidepressant activity through cell-biological steps also recruited by conventional, serotonergically based antidepressants but triggers these through different molecular pathways.
Learned Safety Reduces Learned Contextual and Unlearned, Innate Fear We produced learned safety by a conditioned inhibition of fear protocol in which the animal learns about a stimulus-the safety signal-that indicates the absence of impending aversive events. We and others have found that the behavioral response triggered by the safety signal can become independent from the context in which it has been acquired and might even be effective to control a different, unconditioned response (Denniston et al., 1998; Rogan et al., 2005) . We now find that the safety signal in itself contains an autonomous informational content that can be transferred and lead to reduction in unlearned, innate fear in the elevated plus maze.
Learned Safety Reduces Depression-like Behavior in Two Animal Models
We used two animal models of depression to test the idea that the safety signal may come to indicate a general ''relief period'' from ongoing stress and thus may counteract depressive states. We found an antidepressant effect in the forced-swim test (similar and in magnitude comparable to pharmacological treatment with fluoxetine) and complemented this result by the rescue of chronic mild stress-induced reduction in sucrose preference by the safety signal, similar to that obtained with pharmacological antidepressants (Gittos and Papp, 2001; Moreau et al., 1996) .
Antidepressant pharmacotherapy is more effective in patients with depressive disorders than in healthy controls. The enhancement of the learned safety response in mice, in which a depressive state has been induced by chronic mild stress, resembles this situation in humans and supports learned safety as an animal model of behavioral antidepressant treatment with good face and content validity.
Learned Safety Shares Neurobiological Hallmarks of Pharmacological Antidepressants
Many pharmacological antidepressants and other interventions achieving antidepressant effects increase neurogenesis, whereas, conversely, stress typically reduces neurogenesis (Warner-Schmidt and Duman, 2006; Dranovsky and Hen, 2006; Malberg and Duman, 2003) . We found that in the ''survival paradigm'' learned safety enhances the number of BrdU-positive cells in the dentate gyrus 14 days after BrdU labeling. The number of new cells in the dentate gyrus increases between 2 hr and 1 week after DNA synthesis and then declines rapidly by the 2 week time point (Cameron et al., 1993) . The ability of learned safety to rescue cells that were generated shortly before the training procedure provides a direct link between newborn cells in the adult hippocampus and this behavioral paradigm. These results on neurogenesis add further significance to the behavioral results suggestive of an antidepressant activity of learned safety. The fact that we observed an enhanced survival of those cells that were generated before training but did not observe an effect when BrdU was injected after training suggests that the effect of learned safety on newborn cells may occur only during a specific ''sensitive period'' following the generation of these cells. Interestingly, it is precisely within this time frame (between 1 and 2 weeks after mitosis) that adult-generated granule cells of the dentate gyrus appear to be forming connections with the CA3 region (Gould et al., 1999) . Learned safety, thus, may facilitate the integration of these cells into an established circuitry and promote their survival.
Another factor potentially contributing to enhanced cell survival following learned safety may be the increased neurotrophic support by BDNF. BDNF has been shown to be regulated by antidepressant and is thought to oppose the effects of stress on neuronal cells (e.g., inhibiting excitotoxic damage, blocking neuronal atrophy, etc.) by helping to make neurons more resilient to stress and by maintaining basal levels of hippocampal neurogenesis (Nibuya et al., 1995) .
The delayed acquisition of learned safety in mice with ablated hippocampal neurogenesis shows that neurogenesis is importantly involved in, although not the only process required for, the acquisition of learned safety. For the behavioral antidepressant effects, however, neurogenesis seems to be more essential, since the response to the antidepressant activity of the safety signal in the forced-swim test and the sucrose preference test was blunted in mice with ablated hippocampal neurogenesis. This result is also in agreement with other studies demonstrating ineffectiveness of pharmacological antidepressants in mice with ablated hippocampal neurogenesis (Manev et al., 2001; Santarelli et al., 2003) .
Learned Safety Acts through Molecular Mechanisms Distinct from Conventional Pharmacological Antidepressants
In the search for the molecular basis for the behavioral characteristics and functional properties of learned safety, we turned toward the amygdala, where we have previously identified distinct neural changes in safety-trained mice (Rogan et al., 2005) . We focused on two candidate systems: the dopaminergic and neuropeptidergic Substance P system. The amygdalae are modulated by dopaminergic inputs, which are central for mediating physiological and pathological responses to positive and negative stimuli. Moreover, in animal models of depression, stress has been found to activate the midbrain dopaminergic system by stimulating dopaminergic transmission from the ventral tegmental area (VTA) to its limbic targets, including the amygdala (Di Chiara et al., 1999; Horger and Roth, 1996) . Our finding that sulpiride reduces behavioral despair in the forced-swim test is in agreement with reports on the antidepressant effects of (G) Effect of administration of WAY-100635 before the memory recall test (n = 8 per group) (main effect of phase of testing F (1,32) = 10.098: p < 0.01; effect of interaction between phase of testing and type of training F (1,32) = 43.337: p < 0.001). ''CS effect'' (learned safety vehicle, learned safety WAY-100635, learned fear WAY-100635: p < 0.001; learned fear vehicle: p < 0.01). All data are depicted as mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.0001, n.s. (not significant) p > 0.05. amisulpiride in rats (Papp and Wieronska, 2000) and in humans (for review see Jarema, 2007) . Downregulation of D2R in the course of safety training may act to reduce or relieve the experience of stress and thereby contribute to the antidepressant potential of learned safety.
The parallel regulation of Substance P together with D2R is consistent with a bidirectional feedback mechanism between the two neurotransmitter systems that is thought to be important in mediating associative learning and emotional responses has been recently demonstrated (Kovacs et al., 2006) . We propose a model in which the stress-reducing and antidepressant effects of learned safety are mediated through the interaction of (at least) two different transmitter systems, leading to neuronal modifications typical of pharmacological antidepressant treatment. Stress relief, as a consequence of learned safety, may reduce the firing of dopaminergic cells of the VTA, which in turn leads to downregulation of D2R in the basolateral amygdala. Reduction of dopamine may then inhibit the expression of Substance P mRNA (Kovacs et al., 2006) . Reduced levels of Substance P may then feed back to further reduce the activation of the midbrain dopaminergic system (Renoldi and Invernizzi, 2006) and in part, indirectly through increased expression of BDNF, provide enhanced neurotrophic support to promote the survival of newborn cells in the hippocampus (Morcuende et al., 2003) .
In summary, our findings make three main points. One, learned safety represents an animal model of a behavioral intervention for depression that leads to behavioral outcomes similar to pharmacological interventions. Two, learned safety induces cellbiological changes known to result from antidepressant pharmacotherapy but is mediated through different molecular pathways. Three, learned safety may provide a paradigm for the screening of pharmacological targets for the treatment of depressive disorders and their interaction with behavioral antidepressant strategies.
EXPERIMENTAL PROCEDURES Animals
Male C57BL6/N mice (10-12 weeks old) (Charles River Laboratories, Willington, MA) were used for all experiments. Mice were kept in clear plastic cages with ad libitum food and water, unless otherwise described. All animal procedures described were executed in accordance with National Institute of Health regulations and approved by the institutional Animal Care and Use Committees of Columbia University and the New York State Psychiatric Institute.
Behavioral Training and Testing
Animals were handled daily for 3 days prior to the safety-or fear-training procedure. In case of the pharmacology experiments, mice were injected i.p. with saline in the course of each of these handling sessions. All behavioral conditioning paradigms and control protocols were carried out over 3 days, followed by a test day 24 hr after the last training day. Training for all animals occurred in behavioral chambers (MED Associates, VT) housed within a soundproof box.
Safety conditioning consisted of four explicitly unpaired US and CS presentations (one session per day for 3 days). The fear conditioning protocol was matched to the number of auditory CS and shock US presentations of the safety conditioning paradigm and thus constituted four paired CS-US presentations per day (see Figure 1A for details). In tone-alone controls, four CS were delivered at the same time points as in the safety conditioning protocol. The precise timing of stimuli varied within session and across days. A memory recall test, consisting of the sole presentation of one CS (20 s), was carried out 24 hr after the last training day. In any instance, the behavior during the CS period (20 s) was compared to the corresponding length of time (20 s) prior to the onset of the CS (pre-CS period). For the fear conditioning retardation test, previously safety-conditioned mice were trained in a simple fear conditioning paradigm (consisting of three CS-US pairings) starting 24 hr after the last day of safety training. Control mice were naive (handled only) prior to fear conditioning. Freezing to the tone was evaluated on the following day in a novel context. In each instance, the US was a scrambled footshock (0.6 mA) delivered for 2 s through the bars of the conditioning chamber. The CS was a software-generated 350 Hz pulsed tone (2 ms rise time, 2% duty cycle) at 72 dB with a total duration of 20 s. For the differential tone testing, the second, unconditioned tone was a software-generated 50 Hz steady tone at 72 dB with a total duration of 20 s. For this experiment, mice were exposed to four presentations of the CS* after the handling period (day 4). All freezing behavior was evaluated by digital video recordings analyzed with FreezeFrame software (Actimetrics, Evanston, IL).
Forced-Swim Test
The forced-swim test was carried out as described elsewhere (Dulawa et al., 2004) . The last 4 min of the 6 min test were scored by analysis of videotapes for immobility. To evaluate the effects of the delivery of the auditory CS on immobility in conditioned mice, the CS was presented during minutes 4 and 5. The time spent immobile during these 2 min was averaged and compared to the average of the time spent immobile during minutes 3 and 6. Unpredictable Chronic Mild Stress The protocol to induce UCMS was adapted from Goshen et al. (2007) . X-irradiated and sham control mice were allowed a 5 week recovery period before being subjected to the UCMS protocol.
Sucrose Preference Test
The sucrose preference test was modified from Yu et al. (2007) . Twelve hours after exposure to the last stressor of the UCMS regime, animals were deprived of food and water and tested for sucrose preference 23 hr later. Testing was carried out in the home cage in the form of a two bottle choice paradigm (2% sucrose versus water) in the presence of the CS for 1 hr. Sucrose preference rate was calculated according to the formula: % preference = [(sucrose intake/total intake) 3 100%].
Elevated Plus Maze
The elevated plus maze test was carried out as described (Shumyatsky et al., 2002) . During the 5 min of testing, the auditory CS was delivered during minutes 3 and 4, and the time spent (in seconds) and entries in the different compartments (closed and open arms) were averaged and compared to the average of the no-CS period (minutes 2 and 5).
Pharmacology Chemicals All drugs were purchased from Sigma Aldrich (Sigma, St. Louis, MO). Sulpiride was dissolved in 0.9% physiological saline and was adjusted to a neutral pH. L703,606 was dissolved in 0.9% physiological saline and 0.5% v/v DMSO. Fluoxetine was dissolved in distilled water. WAY100635, quinprinole, and [Sar9, Met(O2)11]-Substance P were dissolved in 0.9% physiological saline. Drug Administration Sulpiride (20 mg/kg) was injected 45 min, L703,606 (1 mg/kg), WAY100635 (1 mg/kg), and quinprinole (0.1 mg/kg) were injected 30 min, and [Sar9, Met(O2)11]-Substance P (0.5 mg/kg) was injected 20 min prior behavioral experiments. For the forced-swim test, fluoxetine (15 mg/kg) was injected in a repeated-injection schedule at 24 hr, 5 hr, and 1 hr prior to the forcedswim test. All drugs were injected i.p., and the final injection volume was 5 ml/kg in each case.
X-Ray Irraditation Procedure
Mice received fractionated low-dose x-irradiation to the head, as previously described (Santarelli et al., 2003) .
Doublecortin Immunohistochemistry
Doublecortin immunohistochemistry was performed as previously described (Holick et al., 2008) .
Analysis of Neurogenesis
Mice were administered BrdU (50 mg/kg i.p.) [(+)-5 0 bromo-2 0 -deoxyuridine; 97%; Sigma, St. Louis, MO] twice per day (8 hr interval) for 3 days prior to safety or fear conditioning and sacrificed 14 days after the first BrdU injection for assessment of survival of the newborn cells (''survival paradigm''). For assessment of stimulation of neurogenesis, BrdU was administered four times (every 2 hr) starting 2 hr after termination of safety or fear conditioning, and mice were sacrificed 24 hr after the last BrdU injection (''proliferation paradigm''). After anesthesia with ketamine/xylazine, mice were transcardially perfused with 4% paraformaldehyde (PFA) in 0.1 M phosphate-buffered saline (PBS; pH 7.4). Brains were collected and postfixed overnight in 4% PFA at 4 C.
The following day, serial coronal sections (30 mm) along the entire rostrocaudal extension of the hippocampus were cut on a vibratome and stored in a cryoprotective solution (30% ethylene glycol, 30% glycerol in 0.1 M PBS) at À20 C until further processed. BrdU immunohistochemistry was performed on every tenth free-floating section (n = 4 per group), essentially as described elsewhere (Wojtowicz and Kee, 2006) .
BDNF Immunofluorescence
Animals were sacrificed 4 hr after the last day of training, and brains were processed as described above for BrdU analysis. BDNF immunohistochemistry was performed on every sixth section from each animal (n = 4 per group). Sections were rinsed in 0.1 M PBS (at pH 7.4) before incubating for 1 hr in blocking solution (0.1 M PBS, 0.3% Triton X-100, 10% fetal bovine serum). Sections were then incubated with a monoclonal anti-human BDNF antibody (Promega, Imaging and Quantification of BrdU, BrdU/NeuN, and BDNF Immunofluorescence Hippocampal BrdU labeling was quantified according to a modified unbiased stereology protocol by an experimenter blind to the experimental condition (Gould et al., 1999; West et al., 1991) . Confocal images were acquired using an Olympus Fluoview FV1000 scanning module with an Olympus IX81 microscope (Olympus America, Center Valley, PA). BrdU/NeuN double labeling was carried out essentially as described elsewhere (Meshi et al., 2006) . Quantification of BDNF immunofluorescence intensity was performed according to a published method (Gazzaley et al., 1996) .
Gene Expression Analysis
Brain Dissection Animals were sacrificed by cervical dislocation 4 hr after the last training day. Brains were rapidly dissected out, snap-frozen, and stored at À80 C until needed. Eight micrometer brain sections were sliced with a cryostat and immediately stored at À80 C in a dry container.
Laser Capture Microdissection A total of three coronal sections of the amygdala per animal (n = 5 per group) were subjected to LCM. The left and right basolateral nucleus of the amygdala of sections from the rostral (Bregma À0.82 mm), medial (Bregma À1.34 mm), and caudal (Bregma À1.82 mm) amygdala were used for LCM. Brain sections were removed from À80 C and immediately dehydrated in a gradient alcohol series and a final incubation in xylene for clearance. Sections were then airdried under a laminar flow and immediately used for LCM. LCM was carried out using a PixCell II system (Arcturus Bioscience Inc., Mountain View, CA). Selected regions were lifted onto CapSure LCM plastic caps (Arcturus Bioscience Inc.) using a spot size of 15 mm, a laser power of 50 mV, and a duration of 2 ms. Caps with transfer films with the microdissected tissue were immediately placed into Eppendorf tubes containing lysis buffer, incubated at 37 C for 30 min, and stored in À80 C before RNA isolation. Total RNA was extracted from samples collected by LCM caps using RNAqueous-Micro Kit (Ambion Inc., Austin, TX) including DNase treatment to remove potential genomic DNA contamination according to the manufacturer's instructions.
Microarray Experiments
Two rounds of linear amplification were carried out using the GeneChip TwoCycle Target Labeling kit (Affymetrix Inc., Santa Clara, CA) according to the supplier's instruction. cRNA samples derived from single animals were hybridized in recommended buffers to microarrays (Affymetrix GeneChip Mouse Genome 430A 2.0 Array). The samples were stained and washed according to the manufacturer's protocol on a Fluidics Station 400 (Affymetrix Inc.) and scanned on a GeneArray Scanner (Affymetrix Inc., Santa Clara, CA). Primary data extraction was performed with Microarray Suite 5.0 (Affymetrix Inc., Santa Clara, CA). Data were filtered and sorted by a sequential analysis using GeneSpring GX 7.3 software (Affymetrix Inc., Santa Clara, CA). Briefly, raw values were normalized using the GCRMA algorithm (Lim et al., 2007) , filtered for 2-fold expressional changes, and subjected to statistical analysis using a nonparametric using two-way analysis of variance. Genes with significant effects were selected by adjusting the resulting p values for multiple testing by means of the false discovery rate using the linear step-up procedure (BH) of Benjamini and Hochberg (Reiner et al., 2003) .
Reverse Transcriptase-PCR Total RNA was diluted to a final concentration of 100 ng/ml and reverse transcribed using the SuperScript First-Strand synthesis system for RT-PCR (Invitrogen Corporation, Carlsbad, CA) following the supplier's manual. Two microliters of the RT reaction was subjected to PCR amplification using the AccuPrime DNA polymerase system (Invitrogen Corporation, Carlsbad, CA) following the supplier's manual. The primer pairs for the dopamine D2 receptor, substance P, and GAPDH and respective amplification conditions were based upon published protocols (Ding et al., 2007; Mutiara et al., 2006; Silva et al., 2006) . PCR products were separated by electrophoresis on a 1.5% agarose gel and stained with ethidium bromide. Band signals were analyzed and quantified by densitometry analysis using the Kodak Gel Logic 100 imaging system and software. Relative intensities were calculated by normalization to the band intensity levels of GAPDH.
Data Analysis
For analyses of all behavioral experiments involving comparisons between the CS and the pre/no-CS period, repeated-measures ANOVAs were used, with phase of testing as the repeated measure (within-subject factor). Type of training, drug, or UCMS were between-subject factors. Significant main effects or interactions were followed by Tukey-Kramer post hoc tests or paired or unpaired two-tailed Student's t tests where appropriate. For the sucrose preference test, 2 (X-ray: sham or x-irradiated) 3 2 (type of training: safety or control) 3 2 (stress: UCMS or control; for the experiment involving x-irradiated mice) ANOVAs were performed. Histological and RT-PCR data were analyzed using one-way ANOVA followed by Tukey-Kramer post hoc tests for pair-wise comparisons for significant ANOVA results. A a level of 0.05 was adopted in all instances. All analyses were carried out using StatView software (SAS Institute, Cary, NC).
SUPPLEMENTAL DATA
The Supplemental Data include figures and tables and can be found with this article online at http://www.neuron.org/supplemental/S0896-6273(08)00746-0.
